BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Biotech/Pharma - Finance
Amarantus BioSciences, Inc. Closes $5 Million Preferred Stock Financing 4/27/2015
Buy Vertex (VRTX) Now for $45B Or Risk It All, Analyst Tells Gilead (GILD) 4/24/2015
South San Francisco's Veracyte, Inc. (VCYT) Brings In $40 Million 4/23/2015
Jounce Infused With $56 Million to Develop Cancer Immunotherapy Programs 4/23/2015
Stealth SoCal Startup Metacrine Eyes $33 Million and Talent-Cash From Seragon Alums? 4/22/2015
New York VC Firm Oberland Capital Secures $425 Million for Life Sciences, Medtech 4/22/2015
SciFluor Life Sciences, LLC Locks In $30 Million and Taps Ex-Neurogen Corporation (NRGN) CEO as Chairman 4/22/2015
Cambridge's Dimension Therapeutics Nabs $65 Million 4/21/2015
Brandon Capital Partners Dedicates $200 Million to Seeking the Next Big Thing 4/20/2015
Boston VC Firm Atlas Venture Set Sights on Biotech Startups With $280 Million Fund and New Home 4/17/2015
Medican Enterprises Extends Closing On Two Phoenix Area Properties 4/17/2015
This San Francisco Startup Wants to be the Salesforce of Biotech 4/16/2015
Life Science Start-Ups Salivate, As NEA Announces Record-Setting $3.1B Funds 4/16/2015
Biologics, Inc. (NC) Secures Over $29 Million In Copay Assistance For Cancer Patients In 2014 4/15/2015
Ascenion GmbH's Portfolio Company OMEICOS Therapeutics Raises EUR 6.2 Million In Series A To Advance Lead Candidate In Atrial Fibrillation 4/15/2015
StemBioSys Closes $8 Million Series A Financing 4/14/2015
Castle Biosciences Secures $6 Million Credit Facility From Silicon Valley Bank 4/14/2015
Innocrin Pharmaceuticals Raises $28 Million in Series D Financing 4/14/2015
Clyde Biosciences, A Leading Drug Toxicity Testing Company, Closes Series A Investment 4/14/2015
Voyager Therapeutics Snags $60 Million With "Crossover" Investors as Analysts Predict an IPO 4/13/2015
Fidelity CEO Uses Personal Fortune to Bet on Cancer Related IPOs Like Coherus, Adaptimmune and Blueprint Medicines 4/13/2015
Angionetics Initial Equity Funding To Advance As Independent Company To Develop And Commercialize Phase 3 Generx Gene Therapy Product Candidate 4/13/2015
Oxford Finance Closes $20 Million Debt Facility With Inhibrx 4/10/2015
Belgian Start-Up UgenTec Receives Funding From European Investors 4/10/2015
Matinas BioPharma Completes Private Placement Of $10 Million 4/10/2015
Embera NeuroTherapeutics, Inc. Secures A-2 Financing To Advance EMB-001 For Addictions Through Phase 1 Clinical Trial 4/10/2015
Edge Therapeutics Banks $72.5 Million for Phase III Brain Hemorrhage Study 4/9/2015
Silence Therapeutics Scrounges Up $58 Million to Expand RNA Research 4/9/2015
Ark Biosciences Of Shanghai Completes Series A Funding 4/8/2015
Raising $10M in Series A, Alzheon CEO Bets He Can Beat Biogen (BIIB) With World's First Alzheimer's Drug 4/8/2015
Nabriva Raises $120 Million, Headed to Phase III for New Antibiotic 4/7/2015
True North Therapeutics CEO Delivers With $35 Million to Take Lead Candidate Into Clinical Trial 4/7/2015
Gilead (GILD) and Amgen (AMGN) Hand Out Dividends; Other Biotechs Feel the Heat So Who's Next? 4/7/2015
National MS Society Invests $28 Million In New Research To Stop Multiple Sclerosis, Restore Function And End MS Forever 4/7/2015
MicroBiome Therapeutics LLC Reports Advances In Three Microbiome Modulator Programs As It Launches Series B Financing 4/7/2015
CeraPedics, Inc. Announces Closing Of Loan And Equity Financing 4/7/2015
Cellular Biomedicine Group (CBMG) Announces Closing Of $19.6 Million Private Placement Offering 4/7/2015
PhoreMost Ltd Founded To Identify New Druggable Targets For Therapeutics 4/7/2015
MicroBiome Therapeutics LLC Reports Advances In Three Microbiome Modulator Programs As It Launches Series B Financing 4/7/2015
Euclises Pharmaceuticals Completes Financing Round 4/7/2015
Neuronascent Secures Financing For Development Of Its Alzheimer's Therapeutic 4/7/2015
Quebec Breast Cancer Foundation Release: Breast Cancer: $4.5 Million For Nine Homegrown Researchers 4/7/2015
Bay Area's Lux Capital Banks $350 Million to Back Daring Life Science Entrepreneurs With a Futuristic Vision 4/6/2015
Taubman Institute Receives $3 Million Wexner Gift To Support Emerging Physician-Researchers 4/6/2015
MabVax Therapeutics, Inc. Announces Closing Of Financing 4/6/2015
Northwest Biotherapeutics (NWBO) Announces $40 Million Financing 4/2/2015
Caribou Biosciences Raises $11 Million In Series A Funding 4/2/2015
aTyr Pharma $76 Million Series E Gets IPO Rumors Flying 4/2/2015
Thrasos Scores $21M to Complete Phase II THR-184, Expands Renal Portfolio 4/1/2015
Alzheimer's Drug Discovery Foundation Funds Signum Biosciences to Move Novel Therapeutics Towards Clinic 3/31/2015
Tiziana Life Sciences Plc Placing To Raise £2.55 Million 3/31/2015
Algal Scientific Secures $7 Million In Funding To Accelerate Its Efforts To Transform The World’s Food Supply 3/31/2015
Cynapsus Therapeutics (CYNAF) Announces CAD$21 Million Private Placement 3/31/2015
Novan Therapeutics Secures $50 Million Private Financing; Funds Intended to Advance SB204 into Phase 3 3/30/2015
Alzheimer's Disease Research And The Ellison Foundation: Investing $6 Million In A Precision Medicine Approach At UW Medicine 3/30/2015
ImmunoGen (IMGN) Announces $200 Million Non-Dilutive Royalty Transaction 3/30/2015
CoreRx Grabs $7M for Expansion, Plans to Increase Staff By 40% 3/27/2015
Ex-Teva (TEVA) CEO Levin Finds New Home at Neuro Startup Ovid Therapeutics, As It Raises $5M 3/27/2015
Gelesis Closes $22M Equity Financing 3/26/2015
Redx Pharma To Raise £15 Million On Stock Market Debut 3/26/2015
Repositive Ltd Raises £300k Seed Funding To Launch Genomic Data Discovery Platform 3/26/2015
Early-Stage Biotech Star Flagship Ventures Scores $537M for New Fund 3/26/2015
Gelesis Reels in $22M More, Increases Clinical Trials for Gelesis100 3/26/2015
BioPharm Executive: Why Your Last Investment Blew Up 3/26/2015
Horizon Discovery Group plc And Partners Awarded Up To £6.2 Million Funding Under Advanced Manufacturing Supply Chain Initiative 3/25/2015
FLAG Therapeutics Awarded A North Carolina Biotechnology Center Small Business Research Loan To Advance Its Lead Oncology Drug 3/25/2015
Led By Ex-Elan (ELN) Execs, Malin Rakes in $350 Million and Looks to Invest in Viamet, Novan Therapeutics 3/25/2015
Boston Startup Semma Therapeutics Reels in $44 Million; In Process of Hiring and Leasing Lab Space 3/25/2015
Rigontec GmbH Raises €4.8 Million In A Second Closing Of Its Series A Financing 3/24/2015
Eli Lilly (LLY),Novartis AG (NVS)-Backed Startup, Aeglea, Nabs $44 Million 3/23/2015
Nymox Pharmaceutical (NYMX) Announces Private Placements Of $400,000 3/23/2015
Joined Polish Investment Fund Management Release: Poland’s First Institutional Venture Capital Fund Dedicated To Life Science Announces First Closing At $ 42 Million 3/23/2015
Anthera, Inc. Announces $3 Million Research Award From Cystic Fibrosis Foundation Therapeutics, Inc. For Development Of Sollpura - A Novel Enzyme Therapy 3/20/2015
Minerva Neurosciences, Inc. (NERV) Completes Private Placement, Raises $31 Million 3/19/2015
MA Life Science Growing: Backed By Eli Lilly (LLY) and Pfizer (PFE), Nimbus Therapeutics Bankrolls $43 Million 3/18/2015
Epizyme (EPZM) Announces Pricing Of Public Offering Of Common Stock 3/18/2015
Johnson & Johnson (JNJ) Announces Strategic Investment Alliance To Combat Dementia Globally 3/17/2015
NanoTherapies Closes Final Round Of Financing For Completion Of New Advanced Development And Manufacturing Facility 3/17/2015
Epizyme (EPZM) Eyes $100 Million for Mid-Stage Trials of a Reacquired Drug 3/17/2015
Big Name VCs Dump $80 Million Into Bay Area Startup Allergen Research 3/13/2015
Led By a Serial Biotech Entrepreneur, Kura Oncology Forges Pact With Johnson & Johnson (JNJ) Unit and Bags $60 Million to Work on Shelved Drug 3/13/2015
Depomed, Inc. (DEPO) Nabs $575 Million Debt Facility From Deerfield, Pharmakon Advisors 3/13/2015
Minerva Neurosciences, Inc. (NERV) Announces $31 Million Financing 3/13/2015
AstraZeneca PLC (AZN)-Backed PhaseBio Locks in $40 Million 3/12/2015
Champions Oncology, Inc. (CSBR) Announces $14 Million Capital Raise 3/12/2015
Inflection Biosciences Raises €725,000 In Second Financing Round 3/11/2015
AmpliPhi Biosciences Corporation (APHB) Announces $13 Million Financing 3/11/2015
BioLineRx Ltd. Closes $28.75 Million Underwritten Public Offering Of Its American Depositary Shares 3/11/2015
Seven Bridges Genomics UK To Receive £1.95 Million To Launch Graph Genome 3/11/2015
AEterna Zentaris (AEZS) Announces Closing Of US$37 Million Public Offering Of Common Shares And Warrants 3/11/2015
Collegium Scores $50 Million to Advance Abuse-Deterrent Opioid 3/10/2015
TapImmune Inc. (TPIV) Receives $1,000,000 From Strategic Investor 3/10/2015
GrayBug Raises $1.74 Million In Series A2 Financing 3/10/2015
Ophthotech Corporation (OPHT) Achieves Second $50 Million Enrollment Milestone Under Ex-US Licensing And Commercial Agreement With Novartis Pharma AG (NVS) For Fovista 3/10/2015
Bill & Melinda Gates Foundation Injects $52 Million Into CureVac 3/9/2015
Tobira Therapeutics Inc. Closes Financing To Support Development Of CVC In Non-Alcoholic Steatohepatitis 3/9/2015
RegeneRx Biopharmaceuticals, Inc. (RGRX) Joint Venture Partner Receives $7.28 Million USD From Korean Government And Venture Fund For U.S. Development Of RGN-259/GBT-201 3/9/2015
Dyadic International, Inc. Raises $2 Million In Private Placement Of Convertible Note 3/9/2015
Addex Therapeutics (ADXN.SW) Raises CHF2.8 million In A Private Placement And Extends Cash Runway Through 2017 3/9/2015
Phico Therapeutics Receives Translation Award To Advance Its SASPject PT4 Aimed At Escherichia Coli And Klebsiella Pneumoniae Towards Clinical Trials 3/9/2015
BioScrip (BIOS) Raises $62.5 Million In Private Placement Of Convertible Preferred Stock And Announces Plan For $20 Million Rights Offering 3/9/2015
iBIO Institute’s PROPEL Startups Raise Over $30 Million In 2014, Total Capital Raised Surpasses $140 Million 3/6/2015
BioLineRx Ltd. Prices $25 Million Underwritten Public Offering Of Its American Depositary Shares 3/6/2015
Amarin (AMRN) Bags $52.8 Million in New Capital 3/6/2015
Backed By Investors Like Ex-Genzyme (GENZ) CEO, Aura Biosciences Locks In $21 Million 3/5/2015
Stanford University Spinout Alkahest Lands $37.5 Million Investment 3/5/2015
CAPNIA, Inc. Announces Receipt Of $3.6 Million From Series B Warrant Exercise And Issuance Of Series C Warrants 3/5/2015
Bayer HealthCare (BAY) Contributes $1 Million To Support Cancer Care Technology Platform 3/5/2015
With Two Ex-Elan (ELN) Execs at the Helm, Bay Area's Serenus Nabs $43 Million 3/4/2015
Bay Area's Tricida Scores $30 Million 3/4/2015
Massachusetts Startup Macrolide Pharma Launches With $22 Million in Pocket 3/4/2015
NovaBay Pharmaceuticals, Inc. (NBY) Announces $4.9 Million Private Placement 3/4/2015
Mersana Therapeutics Nabs $35 Million And A New CEO 3/3/2015
CALBIO15: Investors Will "Set Higher Bar" for Biotech IPOs in 2015 As Market Corrects, Says Panel 3/3/2015
Coronado Biosciences (CNDO) Closes $10 Million Private Placement Financing 3/3/2015
Chrono Therapeutics, Inc. Receives Investment From Rock Health To Advance Smartstoptm Smoking Cessation Technology 3/3/2015
Rheumatology Research Foundation Receives $1 Million Donation For Physician-Driven Medical Research 3/3/2015
BioGenerator Leads Investment In AgTech Company, Apse 3/3/2015
Vascular Pharmaceuticals Completes $9 Million Expansion Of Series A Financing 3/3/2015
Champions Oncology, Inc. (CSBR) Extends Convertible Debt Financing 3/2/2015
ImevaX Welcomes Kfw To Investor Syndicate In Second Closing Of Series A Financing 3/2/2015
Israeli Biotech Chiasma Reels in $70 Million Despite Roche (RHHBY) Pullout 2/27/2015
Gilead (GILD) Holds Cash Overseas to Save Billions on Taxes 2/27/2015
Illumina (ILMN) Accelerator Locks in $40 Million to Back Startups 2/26/2015
AMAG Pharmaceuticals, Inc. (AMAG) Prices Public Offering Of $175 Million Of Common Stock 2/26/2015
Spring Bank Pharmaceuticals, Inc. Completes $22 Million Financing 2/26/2015
Lyric Pharmaceuticals Announces $20.4M Series A Funding Round 2/26/2015
Life Sciences Ontario Release: Life Sciences In Ontario Contribute $38.5 Billion To Province's GDP 2/26/2015
Vectorious Medical Technologies Completes $5M Raise 2/26/2015
BioPharm Executive: Nine Ways to Avoid Investing in Biotech Duds 2/26/2015
PCORI Awards $64.1 Million To Support Five Pragmatic Clinical Studies 2/25/2015
Agile Therapeutics, Inc. Secures Debt Facility From Hercules Technology Growth Capital Of Up To $25 Million And Provides Update On Status Of Clinical Trial 2/25/2015
Eccrine Systems Raises $1.5 Million In Seed Funding 2/25/2015
GeoVax Labs Inc. (GOVX.OB) Announces Equity Financing Of Up To $6 Million 2/25/2015
Neos Therapeutics Completes $20.6 Million Financing To Further Advance Its Late-Stage ADHD Product Pipeline 2/25/2015
Vigilant Biosciences Closes $5.5 Million Series B Round Of Funding 2/24/2015
Calixar Raises €1 Million 2/24/2015
Prexton Therapeutics Raises €8.7 Million ($10 Million) In A Series A Round 2/24/2015
The Medicines Company (MDCO) Will See Dynamic 2015, As Trials, Approvals Gain: Citi 2/20/2015
3SBio Inc. (SSRX) Files for Hong Kong IPO; May Raise Up To $500 Million 2/20/2015
Cambridge Startup Pronutria Nabs $28.3 Million From Five Investors 2/19/2015
Agrimetis Completes A $7.3m Series A 2/19/2015
Novartis AG (NVS)-Backed Startup Merganser Biotech Reels in $28 Million 2/19/2015
Partikula Announces $5 Million Series A Funding To Develop Novel First-In-Class Mitochondrial Targeted Therapeutics 2/18/2015
Revamped Laguna Pharma Reels in $30 Million, Snags a New CEO, and Moves to San Diego 2/18/2015
Dance Biopharma Completes $9.5 Million Private Financing 2/18/2015
TraceLink, Inc. Secures $20 Million To Help Life Sciences Companies Protect Patients From Counterfeit Drugs 2/18/2015
Lineagen, Inc. Announces $19.8 Million Fundraising With Closing Of $15.8 Million Series C Round 2/18/2015
Advaxis, Inc. Completes $23 Million Financing 2/18/2015
IAVI Receives GSK Funding For The Human Vaccines Project To Accelerate Development Of Vaccines For Infectious Diseases And Cancer 2/17/2015
Enterprise Therapeutics Ltd Release: Drug Discovery Company Secures £1.6m ($2.4m) In Initial Series-A Financing From Epidarex Capital 2/17/2015
Bay Area Startup Unchained Labs Grabs $25 Million and Closes First Acquisition 2/13/2015
ACT Genomics Raises $8 Million In Its First Private Funding Round 2/13/2015
Skyepharma PLC (SKYEF) Announces Early Repayment Of The Remainder Of The CRC Finance Facility 2/13/2015
San Diego's Cidara Therapeutics Banks $42 Million Financing 2/12/2015
Cortendo Completes $26.4 Million In Private Placement From Leading U.S. And EU Investors 2/11/2015
NeuroVive Pharmaceutical AB: New Subsidiary Secures Funding Of Just Over USD 3 Million Ahead Of Potential IPO In Taiwan 2/11/2015
Peter Thiel's San Francisco Nonprofit Funds Three More Big Science Startups 2/11/2015
Pfizer (PFE) Commences $5 Billion Accelerated Share Repurchase 2/10/2015
Inoviem Scientific Raises €500,000 ($566,000) In Seed Funding From Cap Innov’Est 2/10/2015
GE Capital Agents $250 Million Financing For Amneal Pharmaceuticals 2/10/2015
Case Western Reserve University Awarded $3.9 Million for Innovative HIV Research 2/9/2015
TONIX Pharmaceuticals, Inc. (TNXP) Announces Closing Of $28.7 Million Public Offering Of Common Stock 2/9/2015
Melinta Therapeutics (Formerly known as Rib-X Pharmaceuticals, Inc.) Locks In $30 Million 2/9/2015
Bio/Med Investor Network Release: Angel Network Formed To Invest In Early-Stage Life Science Companies 2/9/2015
Zedira Receives Further Funding To Develop Factor XIIIa-Blockers For Safe Anticogulation 2/9/2015
With the Help of Two Amgen (AMGN) Scientists, Ex-Dendreon (DNDN) CEO Launches Stealth Next-Gen Immunotherapy Startup in Seattle 2/9/2015
Tiny Startup G1 Therapeutics Grabs $33 Million to Compete With Big Pharma 2/6/2015
Mark Zuckerberg And Priscilla Chan Give $75 Million To Support San Francisco General Hospital And Trauma Center 2/6/2015
GlaxoSmithKline (GSK) Brings Three Banks on Board to Advise on Potential IPO 2/5/2015
GE Corporation (GE), Pfizer (PFE) Face $506 Billion Foreign-Cash Tax in Obama Plan 2/5/2015
Armetheon Closes $24 Million Series B Financing 2/5/2015
ORIG3N™ Closes $3.1 Million In Funding Lead By Hatteras Venture Partners 2/5/2015
Contextual Genomics And The Personalized Medicine Initiative Receive Funding From AstraZeneca PLC (AZN) For National Access Project For Cancer Testing 2/5/2015
Third Rock Ventures Launches $45 Million Bay Area Startup Revolution Medicines to Squeeze More Drugs From Nature 2/5/2015
Harvard University Professor Turned Biotech Master Banks $18 Million for Startup WaVe Lifesciences 2/4/2015
Backed By Eli Lilly (LLY), Roche (RHHBY), and Sanofi (SAN.PA), Startup Lysosomal Therapeutics Bags $20 Million 2/4/2015
American Heart Association Announces $4.6 Million Gift To Expand And Enhance Heart Attack Care In Rural Iowa 2/4/2015
Capricor Therapeutics, Inc. Announces $7 Million Private Placement Of Common Stock 2/4/2015
Cleveland Biolabs Inc. (CBLI) Announces $4.2 Million Financing 2/4/2015
The Eli Lilly (LLY) Foundation Commits $1 Million To Support AMPATH Oncology Institute In Kenya 2/4/2015
AuraSense Therapeutics Adds To Series C Financing 2/4/2015
Plagued By Multiple Facility Break-ins and Bad Management Decisions, Viropro Inc. (VPRO) Implements Restructuring Plan 2/3/2015
Dispersol Technologies Secures Over $10 Million With The Close Of Financing Led By Research Corporation Technologies 2/3/2015
Brickell Biotech Announces $10 Million Series C Financing To Fund Development Of Novel Dermatology Treatments 2/3/2015
Lilly Diabetes Donates $92,000 In Camp Scholarships To The American Diabetes Association 2/3/2015
OrbiMed Launches $924 Million Royalty & Credit Opportunities Fund 2/2/2015
SteadyMed Raises $12.2 Million In Equity Financing 1/29/2015
Medical Research Council Announced A £4.8 Million Investment 1/29/2015
InVivo Therapeutics Corporation (NVIV) Announces $12 Million Registered Direct Offering 1/29/2015
XenoPort, Inc. (XNPT) Announces Pricing Of $100 Million 2.50% Convertible Senior Notes Due 2022 1/29/2015
Exco InTouch Set For Further Growth And Expansion Into Healthcare Markets Through Recent £3.2 Million Investment Round 1/29/2015
Consort Medical Invests £2.2 Million In Atlas Genetics Series C Funding 1/29/2015
Pfizer (PFE)'s $33 Billion Cash Pile Has Everyone Speculating 1/28/2015
Vaccinogen Closes Second Tranche Of $80 Million Financing At $5.50 Per Unit 1/28/2015
BIONEXT Raises €1M In Seed Funding From The Cap Innov'Est Fund And Angel Investors 1/28/2015
Bill & Melinda Gates Foundation, UK Take Lead In $7.5 Billion Pledge For Children's Vaccines 1/28/2015
Vaccinogen Closes Second Tranche Of $80 Million Financing At $5.50 Per Unit 1/28/2015
ONCOLIX, INC. Announces Capital Raise Of $4.2 Million 1/27/2015
TxCell Receives EUR 1.7 Million From Bpifrance For Ovasave® Clinical Development In Refractory Crohn’s Disease 1/27/2015